ImmunityBio, Inc.
IBRX
$8.76
-$0.02-0.17%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/12/2026
-
MarketBeat
IBRX Stock At 3-Month High: Retail Bulls Eye July Catalysts Around Anktiva Saudi Expansion, Q2 Sales
6/30/2026
-
Stocktwits News Feed
6/29/2026
-
Zacks Investment Research
6/27/2026
-
Tickeron - Stocks
6/27/2026
-
The Cerbat Gem
6/26/2026
-
Simply Wall St
6/26/2026
-
Tickeron - Stocks
6/26/2026
-
Tickeron - Stocks
6/25/2026
-
Tickeron - Stocks
6/25/2026
-
Tickeron - Stocks
6/24/2026
-
Simply Wall St
6/24/2026
-
Tickeron - Stocks
6/24/2026
-
Tickeron - Stocks
6/23/2026
-
Tickeron - Stocks
6/19/2026
-
Insider Monkey
6/19/2026
-
Tickeron - Stocks
6/17/2026
-
Tickeron - Stocks
6/17/2026
-
Tickeron - Stocks
6/16/2026
-
Tickeron - Stocks
6/13/2026
-
Tickeron - Stocks
6/12/2026
-
Simply Wall St
6/12/2026
-
Tickeron - Stocks
6/12/2026
-
Tickeron - Stocks
6/11/2026
-
Insider Monkey
9/17/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, May 7, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
844 696 5235
Address
3530 John Hopkins Court
San Diego, CA 92121
San Diego, CA 92121
Country
Year Founded
--
Business Description
Sector
ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient’s immune system and deliver...
more